Abstract
Physiological and pathological vascular responses depend on the action of numerous intercellular mediators, ranging from hormones to gases like nitric oxide, proteins, and lipids. The last group consists not only of the different types of lipoproteins, but also includes a broad array of other lipophilic signaling molecules such as fatty acids, eicosanoids, phospholipids and their derivatives, sphingolipids and isoprenoids. Due to space limitations, it is impossible to discuss all the vascular effects of lipophilic mediators or compounds. Therefore, we will focus on one of the most important lipid-mediated diseases, atherosclerosis. Lipoproteins and especially their native or oxidized lipid compounds affect vascular function in many different ways, and these effects do not only modulate atherogenesis but are of paramount physiological and pathophysiological importance in other diseases, such as inflammation, tumor metastasis, or normal wound healing.
Similar content being viewed by others
Abbreviations
- AP-1:
-
activator protein 1
- EET:
-
epoxy-eicosatrienoic acid
- HDL:
-
high density lipoprotein
- HETE:
-
hydroxy-eciosatetraenoic acids
- HMG-CoA:
-
3-hydroxy-3-methyl-glutaryl CoA
- ICAM-1:
-
intercellular adhesion molecule 1
- LDL:
-
low density lipoproteins
- Lp(a):
-
lipoprotein (a)
- LT:
-
leukotriene
- LX:
-
lipoxin
- MAP kinase:
-
mitogen activated protein kinase
- mmLDL:
-
mildly modified low density lipoprotein
- NFκB:
-
nuclear factor kappa B
- NO:
-
nitric oxide
- oxLDL:
-
oxidized low density lipoprotein
- PAF:
-
platelet-activating factor
- PDGF:
-
platelet-derived growth factor
- PG:
-
prostaglandin
- PKA:
-
protein kinase A
- PKC:
-
protein kinase C
- PUFA:
-
polyunsaturated fatty acids
References
Navab, M., Berliner, J.A., Watson, A.D., Hama, S.Y., Territo, M.C., Lusis, A.J., Shih, D.M., Van Lenten, B.J., Frank, J.S., Demer, L.L., Edwards, P.A., and Fogelman, A.M. (1996) The Yin and Yang of Oxidation in the Development of the Fatty Streak,Arterioscler. Thromb. Vasc. Biol. 16, 831–842.
Creager, M.A., and Selwyn, A. (1996) When “Normal” Cholesterol Levels Injure the Endothelium,Circulation 96, 3255–3257.
Hajjar, D.P., and Haberland, M.E. (1997) Lipoprotein Trafficking In Vascular Cells,J. Biol. Chem. 272, 22975–22978.
Selwyn, A.P., Kinlay, S., Libby, P., and Ganz, P. (1997) Atherogenic Lipids, Vascular Dysfunction, And Clinical Signs Of Ischemic Heart Disease,Circulation 95, 5–7.
Sellmayer, A., Obermeier, H., Danesch, U., Aepfelbacher, M., and Weber, P.C. (1996) Arachidonic Acid Increases Activation of NADPH Oxidase in Monocytic U937 Cells by Accelerated Translocation of p47-Phox and Co-Stimulation of Protein Kinase C,Cell. Signal. 8, 397–402.
Peppelenbosch, M.P., Qiu, R.-G., DeVries-Smits, A.M.M., Tertoolen, L.G.J., DeLaat, S.W., McCormick, F., Hall, A., Symons, M.H., and Bos, J.L. (1995) Rac Mediates Growth Factor-Induced Arachidonic Acid Release,Cell 81, 849–856.
Sellmayer, A., Danesch, U., and Weber, P.C. (1996) Modulation of the Expression of Early Genes by Polyunsaturated Fatty Acids,Prostagland. Leukot. Essent. Fatty. 57, 353–357.
Khan, W.A., Blobe, G.C., and Hannun, Y.A. (1995) Arachidonic Acid and Free Fatty Acids as Second Messengers and the Role of Protein Kinase C,Cell. Signal. 3, 171–184.
Krey, G., Braissant, O., L’Horset, F., Falkhoven, E., Perroud, M., Parker, M.G., and Wahli, W. (1997) Fatty Acids, Eicosanoids, and Hypolipidemic Agents Identified as Ligands of Peroxisome Proliferator-Activated Receptors by Coactivator-Dependent Receptor Ligand Assay,Mol. Endocrinol. 11, 779–791.
Danesch, U., Weber, P.C., and Sellmayer, A. (1994) Arachidonic Acid Increases c-fos and Egr-1 mRNA in 3T3 Fibroblasts by Formation of Prostaglandin E2 and Activation of Protein Kinase C,J. Biol. Chem. 269, 27258–27263.
Geritsen, M.E. (1996) Physiological and Pathophysiological Roles of Eicosanoids in the Microcirculation,Cardiovasc. Res. 32, 720–732.
Jeremy, J.Y., Jackson, C.L., Bryan, A.J., and Angelini, G.D. (1996) Eicosanoids, Fatty Acids and Restenosis Following Coronary Artery Bypass Graft Surgery and Balloon Angioplasty,Prostagland. Leukot. Essent. Fatty 54, 385–402.
Bates, E.J. (1995) Eicosanoids, Fatty Acids and Neutrophils: Their Relevance to the Pathophysiology of Disease,Prostagland. Leukot. Essent. Fatty 53, 75–86.
Serhan, C.N., Haeggström, J.Z., and Leslie, C.C. (1996) Lipid Mediator Networks in Cell Signaling: Update and Impact of Cytokines,FASEB J. 10, 1147–1158.
Palmblad, J., Lerner, R., and Larsson, S.H. (1994) Signal Transduction Mechanisms for Leukotriene B4 Induced Hyperadhesiveness of Endothelial Cells for Neutrophils,J. Immunol. 152, 262–269.
Serhan, C.N. (1997) Lipoxins and Novel Aspirin-Triggered 15-Epi-Lipoxins (ATL): A Jungle of Cell-Cell Interactions or a Therapeutic Opportunity?Prostaglandins 53, 107–137.
Pritchard, K.A., Wong, P.Y.-K., and Stemerman, M.B. (1990) Atherogenic Concentrations of Low-Density Lipoprotein Enhance Endothelial Cell Generation of Epoxyeicosatrienoic Acid Products,Am. J. Pathol. 136, 1383–1391.
Karara, A., Wei, S., Spady, D., Swift, L., Capdevila, J.H., and Falck, J.R. (1992) Arachidonic Acid Epoxygenase: Structural Characterization and Quantification of Epoxyeicosatrienoates in Plasma,Biochem. Biophys. Res. Commun. 182, 1320–1325.
Ellis, E.F., Police, R.J., Yancey, L., McKinney, J.S., and Amruthesh, S.C. (1990) Dilation of Cerebral Arterioles by Cytochrome P-450 Metabolites of Arachidonic Acid,Am. J. Physiol. 259, H1171-H1177.
Fitzpatrick, F.A., Ennis, M.D., Baze, M.E., Wynalda, M.A., McGee, J.E., and Liggett, W.F. (1986) Inhibition of Cyclooxygenase Activity and Platelet Aggregation by Epoxyeicosatrienoic Acids,J. Biol. Chem. 261, 15334–15338.
Pritchard, K., Tota, R.R., Stemerman, M.V., and Wong, P.Y.-K. (1990) 14,15-Epoxyeicosatrienoic Acid Promotes Endothelial Cell-Dependent Adhesion of Human Monocytic Tumor U-937 Cells,Biochem. Biophys. Res. Commun. 167, 977–981.
Sellmayer, A., Uedelhoven, W.M., Weber, P.C., and Bonventre, J.V. (1991) Endogenous Noncyclooxygenase Metabolites of Arachidonic Acid Modulate Growth and mRNA Levels of Immediate-Early Response Genes in Rat Mesangial Cells,J. Biol. Chem. 266, 3800–3807.
Harder, D.R., Lange, A.R., Gebremedhin, D., Birks, E.K., and Roman, R.J. (1997) Cytochrome P450 Metabolites of Arachidonic Acid as Intracellular Signaling Molecules in Vascular Tissue,J. Vasc. Res. 34, 237–243.
Sassen, L.M.A., Lamers, J.M.J., and Verdouw, P.D. (1994) Fish Oil and the Prevention and Regression of Atherosclerosis,Cardiovasc. Drugs Ther. 8, 179–191.
Sellmayer, A., and Hrboticky, N. (1995) Cardiovascular Effects of n-3 Fatty Acids in the Elderly,Cardiol. in the Elderly J. 3, 11–15.
Semplicini, A., and Valle, R. (1994) Fish Oils and their Possible Role in the Treatment of Cardiovascular Diseases,Pharmac. Ther. 61, 385–397.
Weber, C., Erl, W., Pietsch, A., Danesch, U., and Weber, P.C. (1995) Docosahexaenoic Acid Selectively Attenuates Induction of Vascular Cell Adhesion Molecule-1 and Subsequent Monocytic Cell Adhesion to Human Endothelial Cells Stimulated by Tumor Necrosis Factor-α,Arterioscler. Thromb. Vasc. Biol. 15, 622–628.
Sellmayer, A., Obermeier, H., Weber, C., and Weber, P.C. (1993) Modulation of Cell Activation by n-3 Fatty Acids, inn-3 Fatty Acids and Vascular Disease, (DeCaterina, R., Endres, S., Kristensen, S.D., and Schmidt, E.B., eds.) Bi & Gi Publishers, Verona.
Danesch, U., Weber, P.C., and Sellmayer, A. (1996) Differential Effects of n-6 and n-3 Polyunsaturated Fatty Acids on Cell Growth and Early Gene Expression in Swiss 3T3 Fibroblasts,J. Cell. Physiol. 168, 618–624.
Budowski, P. (1996) The Omega-3 Fatty Acid Peroxidation Paradox,Redox Report 2, 75–77.
Esterbauer, H., Dieber-Rotheneder, M., Waeg, G., Striegl, G., and Jürgens, G. (1990) Biochemical, Structural, and Functional Properties of Oxidized Low-Density Lipoprotein,Chem. Res. Toxicol. 3, 77–92.
Patrono, C., and FitzGerald, G.A. (1997) Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease,Arterioscler. Thromb. Vasc. Biol. 17, 2309–2315.
Wang, T., Yu, W-G., and Powell, W.S. (1992) Formation of Monohydroxy Derivatives of Arachidonic Acid, Linoleic Acid, and Oleic Acid During Oxidation of Low Density Lipoprotein by Copper Ions and Endothelial Cells,J. Lipid Res. 33, 525–537.
Heery, J.M., Kozak, M., Stafforini, D.M., Jones, D.A., Zimmerman, G.A., McIntyre, T., and Prescott, S.M. (1995) Oxidatively Modified LDL Contains Phospholipids with Platelet-Activating Factor-Like Activity and Stimulates the Growth of Smooth Muscle Cells,J. Clin. Invest. 96, 2322–2330.
Watson, A.D., Leitinger, N., Navab, M., Faull, K.F., Hörkkö, S., Witztum, J.L., Palinski, W., Schwneke, D., Salomon, R.G., Sha, W., Subbanagounder, G., Fogelman, A.M., and Berliner, J.A. (1997) Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein that Induce Monocyte/Endothelial Interactions and Evidence for their PresenceIn Vivo, J. Biol. Chem. 272, 13597–13607.
Vaughan, C.J., Murphy, M.B., and Buckley, B.M. (1996) Statins Do More than Just Lower Cholesterol,Lancet 348, 1079–1082.
Massy, Z.A., Keane, W.F., and Kasiske, B.L. (1996) Inhibition of the Mevalonate Pathway: Benefits Beyond Cholesterol Reduction?Lancet 347, 102–103.
Hrboticky, N., Sellmayer, A., Young, Y., Pietsch, A. and Weber, P.C. (1996) Linoleic Acid Esterified in Low Density Lipoprotein Serves as Substrate for Increased Arachidonic Acid Synthesis in Differentiating Monocytic Cells,Biochim. Biophys. Acta 1302, 199–206.
Glomset, J.A., and Farnsworth, C.C. (1994) Role of Protein Modification Reactions in Programming Interactions Betweenras-Related GTPases and Cell Membranes,Annu. Rev. Cell. Biol. 10, 181–205.
Ghosh, P.M., Mott, G.E., GhoshChoudhury, N., Radnik, R.A., Stapleton, M.L., and Kreisberg, J.I. (1997) Lovastatin Induces Apoptosis by Inhibiting Mitotic and Post-Mitotic Events in Cultured Mesangial Cells,Biochim. Biophys. Acta. 1359, 13–24.
Sugatani, J., Miwa, M., Komiyama, Y., and Ito, S. (1996) High-Density Lipoprotein Inhibits the Synthesis of Platelet-Activating Factor in Human Vascular Endothelial Cells,J. Lipid. Mediat. Cell. Signal. 13, 73–88.
Calabresi, L., Franceschini, G., Sirtori, C.R., DePalma, A., Saresella, M., Ferrante, P., and Taramelli, D. (1997) Inhibition of VCAM-1 Expression in Endothelial Cells by Reconstituted High Density Lipoproteins,Biochem. Biophys. Res. Commun. 238, 61–65.
Fleisher, L.N., Tall, A.R., Witte, L.D., Miller, R.W., and Cannon P.J. (1982) Stimulation of Arterial Endothelial Cell Prostacyclin Synthesis by High Density Lipoproteins,J. Biol. Chem. 257, 6653–6655.
Karmansky, I., and Nachman, G. (1994) Structure and Possible Biological Roles of Lp(a),Clin. Biochem. 27, 151–162.
Takami, S., Yamashita, S., Kihara, S., Ishigami, M., Takemura, K., Kume, N., Kita, T., and Matsuzawa, Y. (1998) Lipoprotein(a) Enhances the Expression of Intercellular Adhesion Molecule-1 in Cultured Human Umbilical Vein Endothelial Cells,Circulation 97, 721–728.
Beaudeux, J.L., Cesarini, M.L., Gardes-Albert, M., Maclouf, J., Esposito, B., Peynet, J., and Tedgui, A. (1997) Native and Gamma Radiolysis-Oxidized Lipoprotein(a) Increase the Adhesiveness of Rabbit Aortic Endothelium,Atherosclerosis 132, 29–35.
Moers, A., Fenselau, S., and Schrezenmeir, J. (1997) Chylomicrons Induce E-Selectin and VCAM-1 Expression in Endothelial Cells,Exp. Clin. Endocrinol. Diabetes 105 Suppl. 2, 35–37.
Zimmerman, G.A., Elstad, M.R., Lorant, D.E., McIntyre, T.M., Prescott, S.M., Topham, M.K., Weyrich, A.S., and Whatley, R.E. (1996) Platelet-Activating Factor (PAF): Signalling and Adhesion in Cell-Cell Interactions,Adv. Exp. Med. Biol. 416, 297–304.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sellmayer, A., Hrboticky, N. & Weber, P.C. Lipids in vascular function. Lipids 34 (Suppl 1), S13–S18 (1999). https://doi.org/10.1007/BF02562222
Issue Date:
DOI: https://doi.org/10.1007/BF02562222